Revlimid Clinical Trials
Here are the 6 most popular medical studies for revlimid
Monoclonal Antibodies
RLI Therapy for Follicular Lymphoma
Recruiting1 awardPhase 1
Washington, District of Columbia
This trial is testing the side effects and best dose of two drugs, lenalidomide and ibrutinib, when given with a third drug, rituximab, to treat patients with follicular lymphoma that has not been treated before.
Popular filter options for revlimid trials
Phase 3 Clinical Trials
View 98 phase 3 medical studies.
Bisphosphonate
Ixazomib + Lenalidomide + Dexamethasone + Zoledronic Acid for Solitary Plasmacytoma of Bone
Recruiting2 awardsPhase 3
Anchorage, Alaska
This trial is comparing two treatments for a type of bone cancer. One treatment is just radiation therapy, and the other is radiation therapy with drugs that may help kill cancer cells or reduce bone pain. It is not yet known which treatment is more effective.
Monoclonal Antibodies
Daratumumab + Lenalidomide + Dexamethasone for Multiple Myeloma
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial will compare two treatments for people with newly diagnosed multiple myeloma who are not candidates for high-dose chemotherapy and stem cell transplant. The first treatment is daratumumab in combination with lenalidomide and dexamethasone. The second treatment is lenalidomide and dexamethasone. The study will look at how well each treatment works in terms of progression-free survival (PFS).
Clinical Trials With No Placebo
View 98 medical studies that do not have a placebo group.
Chemotherapy
Tafasitamab + Lenalidomide + Maplirpacept for Diffuse Large B-cell Lymphoma
Recruiting1 awardPhase 2
Baton Rouge, Louisiana
This trial is testing 3 medicines to treat relapsed/refractory DLBCL, a type of NHL cancer, to see if they're safe & effective. Participants will receive them through IV infusion & taking a pill.
Proteasome Inhibitor
Dexamethasone + Lenalidomide + Carfilzomib + Isatuximab for Multiple Myeloma
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial is testing an experimental drug combination for people with newly diagnosed multiple myeloma who are eligible for a stem cell transplant. The drugs involved are: Carfilzomib, Isatuximab, Lenalidomide, and Dexamethasone.
Corticosteroid
Lenalidomide + Dexamethasone + Elotuzumab with or without Cyclophosphamide for Primary Amyloidosis
Recruiting1 awardPhase 2
Duarte, California
This trial is testing the combination of lenalidomide, dexamethasone, and eotuzumab with or without cyclophosphamide to treat patients with primary amyloidosis that has come back after a period of improvement.
Bisphosphonate
Ixazomib + Lenalidomide + Dexamethasone + Zoledronic Acid for Solitary Plasmacytoma of Bone
Recruiting2 awardsPhase 3
Anchorage, Alaska
This trial is comparing two treatments for a type of bone cancer. One treatment is just radiation therapy, and the other is radiation therapy with drugs that may help kill cancer cells or reduce bone pain. It is not yet known which treatment is more effective.
View More Revlimid Trials
See another 81 many medical studies focused on revlimid.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.